Canaccord Genuity lowers BioNTech's target price to $132
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data October 15｜Canaccord Genuity has lowered the target price of BioNTech from $136 to $132, maintaining a "Buy" rating.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
October Philadelphia Fed Manufacturing Index Falls More Than Expected
MT newswire•2026/10/15 12:51
Natural Gas: Volatile winter as Persian Gulf LNG stays scarce – ING
FXStreet•2026/10/15 12:43
